Role of cholesterol in parasitic infections

Lipids in Health and Disease

Volumn 4, Issue , 2005, Pages

  Bansal, Devendra ^a   Bhatti, Harinderpal Singh ^a   Sehgal, Rakesh ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ENZYME; MEMBRANE PROTEIN;

ANCYLOSTOMA; ASCARIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CORRELATION ANALYSIS; CRYPTOSPORIDIUM; ENTAMOEBA; FLAGELLATE; GIARDIA; HELMINTH; HUMAN; HYMENOLEPIS; IN VIVO STUDY; LEISHMANIA; LIPID COMPOSITION; LIPID METABOLISM; NONHUMAN; PARASITE; PARASITOSIS; PATHOGENESIS; PLASMODIUM FALCIPARUM; REVIEW; SCHISTOSOMA; TOXOPLASMA; TRICHOMONAS; TRYPANOSOMA; WORM;

ANIMALS; CHOLESTEROL; EUKARYOTA; HUMANS; OXYGEN; PARASITIC DISEASES;

EUKARYOTA; PROTOZOA; VERMES;

EID: 21544463989     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-4-10     Document Type: Review

References (79)

1. Beaver PC, Jung RC, Cupp EW: Clinical Parasitology. Lea & Febiger, 600 Washington Square Philadelphia, PA 19106 USA 1984.
2. Maxfield FR: Plasma membrane microdomains. Curr Opin Cell Biol 2002, 14:483-87.
3. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1:31-9.
4. Faucher JF, Milama EN, Missinou MA, Ngomo R, Kombila M, Kremsner PG: The impact of malaria on common lipid parameters. Parasitol Res 2002, 88:1040-43.
5. Das S, Stevens T, Castillo C, Villasenor A, Arredondo H, Reddy K: Lipid metabolism in mucous-dwelling amitochondriate protozoa. Int J Parasitol 2002, 32:655-57.
6. Rumjanek FD, Campos EG, Afonso LC: Evidence for the occurrence of LDL receptors in extracts of schistosomula of Schistosoma mansoni. Mol Biochem Parasitol 1988, 28:145-52.
7. Rogers MV, Henkle KJ, Fidge NH, Mitchell GF: Identification of a multispecific lipoprotein receptor in adult Schistosoma japonicum by ligand blotting analyses. Mol Biochem Parasitol 1989, 35:79-88.
8. Xu X, Caulfield JP: Characterization of human low density lipoprotein binding proteins on the surface of schistosomula of Schistosoma mansoni. Eur J Cell Biol 1992, 57:229-35.
9. Coppens I, Sinai AP, Joiner KA: Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J Cell Biol 2000, 149:167-80.
10. Aley SB, Cohn ZA, Scott WA: Endocytosis in Entamoeba histolytica. Evidence for a unique non-acidified compartment. J Exp Med 1984, 160:724-37.
11. Fredrickson DS, Levy RI: Familial hyperlipoproteinemia. In In the metabolic basis of inherited disease 3rd edition. Edited by: Stanbury JB, Wyngaarden JB, Fredrickson DS. New York, McGraw-Hill Book co;1972.
12. Tietz NW: Fundamentals of Clinical Chemistry. W.B. Saunders Company Philadelphia, USA; 1994.
13. Kaul D: Do human platelets possess LDL-receptor specific for apoprotein 'B' or cholesterol? Curr Sci 1993, 65:883-86.
14. k and leukemogenesis. Leuk Res 1998, 22:389-94.
15. k regulates the expression of cyclin-dependent kinase inhibitors. Mol Cell Biochem 1999, 200:183-86.
16. k dependent regulation of genes involved in the cell cycle. Mol Cell Biochem 1998, 181:137-42.
17. Kaul D, Khosla VK: Molecular basis of 'cholesterol feedback lesion' in CNS tumors. Nerol India 2000, 48:174-77.
18. Walsh JA: Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of mortality and morbidity. Rev Infect Dis 1986, 8:228-38.
19. Martinez-Palomo A, Martinez-Baez M: Selective primary health care: strategies for control of disease in the developing world X amoebiasis. Rev Infect Dis 1983, 5:1093-02.
20. Sharma R: Effect of cholesterol on the growth and virulence of E. histolytica. Trans Roy Soc Trop Med Hyg 1959, 53:278.
21. Vinayak VK, Chakravarti RN, Agarwal KC, Naik SR, Chuttani PN: Pathogenicity of Entamoeba histolytica - effect of cholesterol on the virulence of strains of amoebae. Indian J Med Res 1978, 67:545-52.
22. Bhatti HS, Bhushnurmath S, Mahajan RC, Ganguly NK, Sehgal R: An experimental model of ameboma in guinea pig. Exp Parasitol 1992, 74:283-289.
23. Singh BN, Srivastava RVN, Dutta GP: Virulence of strain of E. histolytica to rats and the effect of cholesterol, rat caecal and hamster liver passage on the virulence of non-invasive strains. Indian J Expt Biol 1971, 9:21.
24. Gargouri ML: Utilisation du cholesterol bans I'amibiase experimental du cobaye. Ann parasitol Hum Comp 1967, 42:399.
25. Mata-Cardenas BD, Morales-Vallarta M, Vargas-Villarreal J, Said-Fernandez S: PACSR*: a serum replacement for axenic cultivation of Entamoeba histolytica. Trans Roy Soc Trop Med Hyg 1996, 90:586.
26. Laughlin RC, McGuan GC, Powell RR, Welter BH, Temesvari LA: Involvement of raft-like plasma memebrane domains of Entamoeba histolytica in pinocytosis and adhesion. Infect Immun 2004, 72:5349-57.
27. Que X, Reed SL: Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev 2000, 13:196-206.
28. Andra J, Berninghausen O, Leippe M: Membrane lipid composition protects Entamoeba histolytica from self-destruction by its pore-forming toxins. FEBS Lett 2004, 23:109-15.
29. Bansal D, Bhatti HS, Sehgal R: Altered lipid parameters in patients infected with Entamoeba histolytica, Entamoeba dispar and Giardia lamblia. Br J Biomed Sci in press.
30. Adam RD: Biology of Giardia lamblia. Clin Microbiol Rev 2001, 14:447-75.
31. Lujan HD, Mowatt MR, Nash TE: The mechanisms of Giardia lamblia differentiation into cysts. Microbiol Mol Biol Rev 1997, 61:294-304.
32. Gillin FD, Reiner DS, McCaffery M: Cell biology of the primitive eukaryote Giardia lamblia. Annu Rev Microbiol 1996, 50:679-705.
33. Jarrol EL, Muller PJ, Meyer EA, Morse SA: Lipid and carbohydrate metabolism of Giardia lamblia. Mol Biochem Parasitol 1981, 2:187-96.
34. Kaneda Y, Goutsu T: Lipid analysis of Giardia lamblia and its culture medium. Ann Trop Med Parasitol 1985, 82:83-90.
35. Field FJ, Kam NTP, Mathur SN: Regulation of cholesterol metabolism in the intestine. Gastroenterology 1990, 99:539-51.
36. Thomson ABR, Schoeller C, Keelan M, Smith L, Clandinin MT: Lipid absorption: passing through the unstirred layers, brush border membrane and beyond. Can J Physiol Pharmacol 1993, 71:531-55.
37. Lujan HD, Mowatt MR, Nash TE: Lipid requirements and lipid uptake by Giardia lamblia trophozoites in culture. J Euk Microbiol 1996, 43:237-42.
38. Reiner DS, Hetsko ML, Gillin FD: A lipoprotein-cholesterol-albumin serum substitute stimulates Giardia lamblia encystations vesicle formation. J Euk Microbiol 1995, 42:622-27.
39. k regulates giardia encystations process. Mol and Cell Biochem 2001, 225:167-69.
40. Fouts AC, Kraus SJ: Trichomonas vaginalis : reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980, 141:137-143.
41. Bui ET, Johnson PJ: Identification and characterization of [Fe]-hydrogenases in the hydrogenosome of Trichomonas vaginalis. Mol Biochem Parasitol 1996, 76:305-310.
42. Linstead D: New defined and semi-defined media for cultivation of the flagellate Trichomonas vaginalis. Parasitology 1981, 81:125-37.
43. The biology of malaria parasites: Report of a WHO scientific group. WHO Technical Report Series 1987.
44. Das BS, Thurnham DI, Das DB: Plasma α-tocopherol, retinol, and carotenoids in children with falciparum malaria. Am J Clin Nutr 1996, 64:94-100.
45. Davis TME, Sturm M, Zhang YR, Spancer JL, Graham RM, Li GQ, Taylor RR: Platelet-activating factor and lipid metabolism in acute malaria. J Infect 1993, 26:279-85.
46. Mohanty S, Mishra SK, Das BS, Satpathy SK, Mohanty D, Patnaik JK, Bose TK: Altered plasma lipid pattern in falciparum malaria. Ann Trop Med Parasitol 1992, 86:601-06.
47. Kittl EM, Diridl G, Lenhart V, Neuwald C, Tomasits J, Pichler H, Bauer k: HDL-cholesterol as a sensitive diagnostic criterion in malaria. Wien Klin Wochenschr 1992, 104:21-24.
48. Grellier P, Rigomier D, Clavey V, Fruchart JC, Schrevel J: Lipid traffic between high density lipoproteins and Plasmodium falciparum -infected red blood cells. J Cell Biol 1991, 112:267-77.
49. Imrie H, Ferguson DJP, Carter M, Drain J, Schiflett A, Hajdur SL, Day KP: Light and electron microscopical observations of the effects of high-density lipoprotein on growth of Plasmodium falciparum in vitro. Parasitol 2004, 128:577-84.
50. Vial HJ, Eldin P, Tielens AG, Vanhellmond JJ: Phospholipids in parasitic protozoa. Mol Biochem Parasitol 2003, 126:143-54.
51. Sein KK, Aikawa M: The prime role of plasma membrane cholesterol in the pathogenesis of immune evasion and clinical manifestations of falciparum malaria. Med Hypotheses 1998, 51:105-10.
52. Onongbu IC, Onyeneke EC: Plasma lipid changes in human malaria. Tropenmed Parasitol 1983, 34:193-96.
53. Djoumessi S: Serum lipids and lipoproteins during malaria infection. Pathol Biol 1989, 37:909-11.
54. Nilson EI, Nilson EP: Changes in plasma lipoproteins in acute malaria. J Intern Med 1990, 227:151-55.
55. Baptisa JL, Vervoort T, Vander SP, Wery M: Changes in plasma lipid levels as a function of Plasmodium falciparum infection in Sao Tome. Parasite 1996, 3:335-40.
56. Brotons C, Ribera A, Perich RM, Abrodos D, Magana P, Pablo S, Terradas D, Fernadez F, Permanyer G: Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis 1997, 139:1-9.
57. Holliman RE: Toxoplasmosis:. In Manson's tropical diseases 20th edition. Edited by: Gordon Cook. London: WB Saunders; 1996:1246-1254.
58. Coppens I, Joiner KA: Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle. Mol Bio Cell 2003, 14:3804-20.
59. Sonda S, Ting LM, Novak S, Kim K, Maher JJ, Farese RV, Ernst JD: Cholesterol esterification by host and parasite is essential for optimal proliferation of Toxoplasma gondii. J Biol Chem 2001, 276:34434-40.
60. Yoshikawa H, Kimata I, Iseki M: Heterogenous distribution of membrane cholesterol at the attachment site of Cryptosporidium muris to host cells. J Eukaryot Microbiol 1997, 44:454-56.
61. Pucadyil TJ, Tewary P, Madhubala R, Chattopadhyay A: Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol 2004, 133:145-52.
62. Rodrigues JC, Attias M, Rodriguez C, Urbina JA, Souza W: Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob Agents Chemother 2002, 46:487-99.
63. Dietze R, Milan EP, Berman JD, Grogl M, Falqueto A, Feitosa TF, Luz KG, Suassuna FA, Marinho LA, Ksionski G: Treatment of Brazilian kala-azar with a short cource of amhocil (amphotericin B cholesterol dispersion). Clin Infect Dis 1993, 17:981-86.
64. Gillett MP, Owen JS: Characteristics of the binding of human and bovine high-density lipoproteins by bloodstream forms of the African trypanosome, Trypanosoma brucei brucei. Biochim Biophys Acta 1992, 1123:239-48.
65. Coppens I, Baudhuin P, Opperdoes FR, Courtoy PJ: Receptors for the Host Low Density Lipoproteins on the Hemoflagellate Trypanosoma brucei: Purification and Involvement in the Growth of the Parasite. Proc Natl Acad Sci USA 1988, 85:6753-57.
66. Green HP, Del Pilar Molina Portela M, St Jean EN, Lugli EB, Raper J: Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J Biol Chem 2003, 278:422-7.
67. Doenhoff MJ, Stanley RG, Griffiths K, Jackson CL: An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol. Parasitology 2002, 125:415-21.
68. Popiel I, Bash PF: Schistosoma mansoni : cholesterol uptake by paired and unpaired worms. Exp Parasitol 1986, 61:343-47.
69. Silveira AM, Friche AA, Rumjanek FD: Transfer of (14C) cholesterol and its metabolites between adult male and female worms of Schistosoma mansoni. Comp Biochem Physiol B 1986, 85:851-57.
70. el-Marzouki ZM, Amin AM: Changes in serum lipids of mice experimentally infected with Schistosoma mansoni. Egypt Soc Parasitol 1997, 27:419-29.
71. Wiedermann U, Stemberger H, Unfried E, Widhalm K, Kundli M, Altenriederer M, Savedra M, Wiedermann G: Intestinal worm burden and serum cholesterol or lipid concentration in a Shipibo population (Peru). Zentrabl Bakteriol 1991, 275:279-86.
72. Biadun W: Studies of serum lipids in guinea pigs with larval ascariasis. Wiad Parazytol 1990, 36:15-26.
73. Urban JF, Douvres FW, Xu S: Culture requirement of Ascaris suum larvae using a stationary multi-well system: increased survival, development and growth with cholesterol. Vet Parasitol 1984, 14:33-42.
74. el-Naggar HM, Abou-Zakham AA, Romia SM, Hegazi MM, el-Khouly ES: Axenic growth in vitro of Ancylostoma duodenale to the filariform (resting) larvae. J Egypt Soc Parasitol 1991, 21:127-34.
75. Srivastava SC: Liver plasma membrane-bound enzymes and lipids in golden hamsters infected with Ancylostoma ceylanicum. Int J Parasitol 1994, 24:249-51.
76. Joshi A, Saxena JK, Murthy PK, Sen AB, Ghatak S: Brugia malayi: status of host during different stages of infection. Folia Parasitol 1989, 36:169-75.
77. Rath EA, Walkey M: Fatty acid and cholesterol synthesis in mice infected with the tapeworm Hymenolepis microstoma. Parasitol 1987, 95:79-92.
78. Johnson WJ, Cain GD: Studies on the mechanism of cholesterol uptake by the rat tapeworm Hymenolepis diminuta (Cestoda). Comp Biochem Physiol B 1988, 91:59-67.
79. Johnson WJ, Cain GD: The selective uptake of cholesterol uptake by the rat tapeworm Hymenolepis diminuta (Cestoda). Comp Biochem Physiol B 1988, 91:51-58.